INSIGHTS & NEWS
Expert analysis, pre-IPO news, and daily market updates on unlisted shares.
How to Sell Unlisted Shares in India: Complete 2026 Guide | Unlisted Axis
A complete 2026 step-by-step guide to selling unlisted shares in India — covering lock-in rules, the demat off-market transfer process, documents required, costs, tax treatment, and common seller mistakes to avoid.
NCDEX Unlisted Share Price 2026: Complete Investor Guide | Buy, Risks & Returns
Looking to invest in NCDEX unlisted shares in 2026? This complete investor guide covers NCDEX unlisted share price today, financials, how to buy, risks, taxation, and a comparison with MCX — everything a beginner or seasoned investor needs before taking the plunge.
MSEI Unlisted Share Price 2026: Complete Buyer's Guide | Unlisted Axis
Check the latest MSEI unlisted share price in 2026, company financials, listing outlook, and how to safely buy Metropolitan Stock Exchange of India shares through KYC-verified dealers.
NSE Q4 FY26 Results Explained: What Happened & What's Next
India's largest stock exchange NSE reported strong Q4 FY26 numbers even as full-year profits fell 15%. This beginner's guide explains why the annual dip happened, what drove the Q4 recovery, the significance of the ₹35 dividend, NSE's much-awaited IPO timeline, and what FY27 could look like — all in plain, jargon-free language.
NSE Unlisted Share Price 2026: Complete Investor Guide | Unlisted Axis
Get the latest NSE unlisted share price in 2026, company financials, IPO listing status, and a step-by-step guide to buying NSE pre-IPO shares safely through verified dealers in India.
What Are Unlisted Shares? Complete Beginner's Guide 2026 | Unlisted Axis
Discover what unlisted shares are, how they work in India, tax rules for 2026, and how to start investing in pre-IPO companies safely. A complete beginner's guide by NISM-certified experts at Unlisted Axis.
How to Buy Unlisted Shares in India: Complete Step-by-Step Guide 2026 | Unlisted Axis
Want to buy unlisted shares in India? This 2026 step-by-step guide covers everything — demat account setup, finding a verified dealer, KYC, payment, taxes, and how to sell. Includes a comparison of platforms and a full FAQ.
Tata Capital Unlisted Share Price 2026 : Buyer's Guide
Tata Capital unlisted share price is ~Rs. 800 in May 2026. Get the complete buyer's guide — price history, financials, IPO timeline, how to buy, risks, and FAQs. Updated for 2026.
SK Finance Limited – FY26 Result Analysis and P/B Valuation
SK Finance Limited has delivered its strongest year ever in FY26 — AUM crossed ₹15,755 crore, net PAT surged to ₹431 crore, and disbursements topped ₹9,162 crore. For investors in the unlisted share market, this report breaks down every key financial metric, analyses asset quality vs. NBFC peers, and provides a granular P/B valuation framework to assess whether the current unlisted price offers a compelling entry ahead of the SEBI-approved IPO.
OYO Unlisted Shares: Turnaround Story or Overpriced Optimism.
OYO's unlisted shares have fallen from ₹55+ to ₹21–27, even as the company posted its first profitable year in FY24 and accelerated that growth into FY25. So is this a buying opportunity or a value trap? This deep-dive analysis covers OYO's business model, audited financials, IPO timeline, SoftBank complications, and the full risk matrix — giving unlisted share investors the framework they need to decide for themselves.
How to Read a DRHP: For Pre-IPO Investors
Before you invest in an unlisted share, the DRHP is your most powerful due-diligence tool. This guide walks beginner investors through every key section of a Draft Red Herring Prospectus — from promoter history and financial health to risk factors and IPO objectives — so you can make informed decisions in the pre-IPO market.
Bagmane REIT IPO 2026: Price Band, Dates & Investment Insights
Bagmane REIT IPO opens on May 5, 2026, with a price band of ₹95–100. This beginner-friendly guide explains REITs, key benefits, company details, and whether this office REIT is a good investment opportunity in India.
Share Market CEO Exits Ahead of PhonePe IPO | Fintech News 2026
PhonePe's Share.Market head Ujjwal Jain resigns after a four-year tenure. As the Walmart-backed fintech giant moves closer to its IPO, we break down what this leadership change means — in plain English.
Recode Studios IPO 2026: Date, Price Band, GMP, Financials & Full Review
Recode Studios IPO opens on May 5, 2026, offering investors a fast-growing beauty brand story. Explore its financials, GMP trends, risks, and whether it’s worth investing.
India EM Comeback: 2025 Underperformance Sets Up 2026 Rebound
India's equity markets lagged EM peers through 2025 as valuations corrected and retail money rotated out. Now, with fundamentals stabilizing and HNI interest returning, market observers are watching closely for a structural rebound in 2026.
Securities Markets Code 2025: Unlisted Trading & Listing Reform Explained
India's Securities Markets Code 2025 proposes allowing trading in unlisted companies — a major reform that could reshape the pre-IPO investment landscape. Here's what every beginner investor needs to know.
PharmEasy's Thyrocare Pledge: 10% Repaid, ₹1,080 Crore Still at Risk
API Holdings repaid ₹120 Crore of its ₹1,200 Crore NCD debt in March 2026 — but not a single Thyrocare share has been released from pledge. With 60.93% of Thyrocare's equity still encumbered and ₹1,080 Crore outstanding, the overhang on the stock remains very much intact. Here's the full story, timeline, and what investors should watch.
PPFAS Gets PFRDA Approval to Launch Pension Fund Under NPS
PPFAS Asset Management has received approval from PFRDA to sponsor a pension fund under the National Pension System (NPS). This marks a significant development in India’s retirement ecosystem, opening new opportunities for long-term investors and strengthening the country’s pension infrastructure.
HDFC Securities FY26 Results: PAT Falls 17% — Recovery Signs & Unlisted Share Outlook
HDFC Securities reported a 17% decline in FY26 profit, reflecting a challenging year for the broking industry. However, strong Q4 performance signals a potential recovery ahead. This deep-dive covers financials, risks, and the FY27 outlook for unlisted investors.
SBI General Insurance FY26 Analysis: Growth Strong, Profitability Still Catching Up
SBI General Insurance delivered strong premium growth in FY26, outperforming the industry. However, profitability remains under pressure due to a high combined ratio. This deep-dive explores financial performance, key risks, and IPO potential for investors.
Otis Elevator India: Steady Growth, Strong Cash Flow, But Margin Pressure Explained
Otis Elevator India showcases a strong and stable business model driven by recurring maintenance revenue and consistent cash flow. With zero debt and a growing elevator market in India, the company offers long-term potential, but investors must consider risks like unlisted share illiquidity and cost pressures.
Inox Clean Energy’s $750M Boviet Solar Deal: A Strategic Entry into the U.S. Market
Inox Clean Energy is reportedly in advanced discussions to acquire Boviet Solar for $750 million, marking a strategic move into the U.S. solar manufacturing market. The deal offers immediate operational advantages and access to government subsidies, positioning Inox strongly ahead of its potential IPO.
National Coal Exchange of India:Impact on India’s Energy Market
India is moving toward a structured coal trading market with the proposed National Coal Exchange led by the National Stock Exchange of India. This blog explains how the platform aims to improve price transparency, efficiency, and market access—while exploring its impact on investors and the broader commodities ecosystem.
Kissht IPO 2026: Analysis, Dates & Investment Insights
Kissht IPO 2026 brings a profitable fintech player to the market, offering digital lending solutions to underserved customers. With strong backing from Temasek and a ₹926 crore issue size, this IPO presents both growth potential and risk factors investors should carefully evaluate.
API Holdings (PharmEasy) Q3 FY26 Results: Share Price, IPO Plans, CEO Change & Everything You Need to Know in 2026
API Holdings (PharmEasy) Q3 FY26 results highlight a turnaround story, with improving margins and a shift toward profitability after a challenging phase. This blog breaks down financial performance, leadership changes, share price trends, and IPO plans—helping unlisted investors understand the risks and future potential.
RECEIVE UPDATES ON WHATSAPP
Stay Informed With The Latest News.